Reduction in toxicity of doxorubicin by liposomal entrapment.
D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy
D008081:Liposomes; D004317:Doxorubicin